Unibest
← Back to patent-cliff list

CAS 608141-43-1

(S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine (S)-2-acetamido-4-methylpentanoate

Codes: APER-004, APER-026

Application context (from source-drug indications)

Plaque psoriasisApremilastBehçet's syndromeApremilastOral ulcerApremilastPsoriasisApremilastPsoriatic arthritisApremilast

Source drugs (routes using this intermediate)

DrugTierExpiry
ApremilastTier B — Position early2028

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

ApremilastOriginator routesteps: 5total yield: 19.4 g
ApremilastOptimised routesteps: 3total yield: 0.33 g

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.